Tiotropium inhalation solution (Respimat inhaler)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tiotropium inhalation solution (Respimat inhaler), covering 2023-12-01 to 2023-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD [Phase 3]